InsightfulValue
← Home

Ono Pharmaceutical
Ono Pharmaceutical

+7.27%

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Ono Pharmaceutical

πŸ“Š Get full analytics about Ono Pharmaceutical

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

Price
Live  
Overview
Ono Pharmaceutical Co., Ltd. is a Japanese-based pharmaceutical company that was founded in 1717. The company develops, manufactures, and sells prescription medicines and over-the-counter products for a wide range of medical conditions. Ono Pharmaceutical is headquartered in Osaka, Japan and has operations in Asia, Europe, and the United States.
The company focuses on research and development in the fields of oncology, immunology, and neurology. Its products include treatments for cancer, immune disorders, infectious diseases, and other areas of unmet medical need.
Ono Pharmaceutical is committed to ethical business practices and responsible corporate citizenship. The company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of communities it operates in.
Ono Pharmaceutical has collaborations and partnerships with other pharmaceutical companies, research institutions, and universities to enhance its research capabilities and bring innovative medicines to patients.
Overall, Ono Pharmaceutical is dedicated to improving the health and quality of life of individuals worldwide through the development of innovative and effective medications.
What is special about the company?
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

MS4gRm9jdX NlZCBvbiBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn Q6IE9ubyBQ aGFybWFjZX V0aWNhbCBo YXMgYSBzdH JvbmcgZm9j dXMgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCBpbnZlc3 RpbmcgYSBz aWduaWZpY2 FudCBwb3J0 aW9uIG9mIG l0cyByZXZl bnVlIGludG 8gdGhlIGRl dmVsb3BtZW 50IG9mIG5l dyBkcnVncy 4gVGhpcyBo YXMgYWxsb3 dlZCB0aGUg Y29tcGFueS B0byBpbnRy b2R1Y2UgaW 5ub3ZhdGl2 ZSBhbmQgZW ZmZWN0aXZl IHRyZWF0bW VudHMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMuPGJyPj IuIFN0cm9u ZyBQaXBlbG luZSBvZiBE cnVnczogT2 5vIFBoYXJt YWNldXRpY2 FsIGhhcyBh IHJvYnVzdC BwaXBlbGlu ZSBvZiBkcn Vncywgd2l0 aCBzZXZlcm FsIHBvdGVu dGlhbCBibG 9ja2J1c3Rl ciBkcnVncy BpbiBkZXZl bG9wbWVudC 4gVGhpcyBl bnN1cmVzIG EgY29udGlu dW91cyBzb3 VyY2Ugb2Yg cmV2ZW51ZS Bncm93dGgg aW4gdGhlIG Z1dHVyZS48 YnI+My4gR2 xvYmFsIFBy ZXNlbmNlOi BUaGUgY29t cGFueSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBp biBKYXBhbi wgdGhlIFVu aXRlZCBTdG F0ZXMsIGFu ZCBFdXJvcG UuIFRoaXMg YWxsb3dzIG l0IHRvIHRh cCBpbnRvIG RpZmZlcmVu dCBtYXJrZX RzIGFuZCBy ZWFjaCBhIH dpZGVyIHBh dGllbnQgcG 9wdWxhdGlv bi48YnI+NC 4gU3RyYXRl Z2ljIFBhcn RuZXJzaGlw czogT25vIG hhcyBmb3Jt ZWQgc3RyYX RlZ2ljIHBh cnRuZXJzaG lwcyB3aXRo IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyBhbmQgYm lvdGVjaCBz dGFydHVwcy B0byBkZXZl bG9wIG5ldy BkcnVncyBh bmQgdGVjaG 5vbG9naWVz LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdGhl IGNvbXBhbn kgYWNjZXNz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZXhw YW5kIGl0cy Bwcm9kdWN0 IHBvcnRmb2 xpby48YnI+ NS4gQ29tbW l0bWVudCB0 byBJbm5vdm F0aW9uOiBP bm8gUGhhcm 1hY2V1dGlj YWwgaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g aW5ub3ZhdG lvbiBhbmQg aXMgY29uc3 RhbnRseSBp bnZlc3Rpbm cgaW4gbmV3 IHRlY2hub2 xvZ2llcyBh bmQgYXBwcm 9hY2hlcyB0 byBib29zdC BkcnVnIGRl dmVsb3BtZW 50IGFuZCBp bXByb3ZlIH BhdGllbnQg b3V0Y29tZX MuPGJyPjYu IEZvY3VzIG 9uIFJhcmUg RGlzZWFzZX M6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBy YXJlIGRpc2 Vhc2VzLCB3 aGVyZSB0aG VyZSBpcyBh IHNpZ25pZm ljYW50IHVu bWV0IG1lZG ljYWwgbmVl ZC4gVGhpcy Bjb21taXRt ZW50IGhhcy BsZWQgdG8g dGhlIHN1Y2 Nlc3NmdWwg ZGV2ZWxvcG 1lbnQgb2Yg c2V2ZXJhbC BkcnVncyBm b3IgcmFyZS BkaXNlYXNl cy48YnI+Ny 4gU29jaWFs IFJlc3Bvbn NpYmlsaXR5 OiBPbm8gUG hhcm1hY2V1 dGljYWwgaG FzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BhbmQgaXMg Y29tbWl0dG VkIHRvIHBy b3ZpZGluZy BhZmZvcmRh YmxlIGFuZC BhY2Nlc3Np YmxlIG1lZG ljaW5lcyB0 byBwYXRpZW 50cyBpbiBu ZWVkLjxicj 44LiBTdHJv bmcgRmluYW 5jaWFsIFBl cmZvcm1hbm NlOiBUaGUg Y29tcGFueS BoYXMgY29u c2lzdGVudG x5IGFjaGll dmVkIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggc3RlYWR5 IHJldmVudW UgYW5kIHBy b2ZpdCBncm 93dGguIFRo aXMgc3RhYm lsaXR5IGFu ZCBmaW5hbm NpYWwgc3Ry ZW5ndGggZ2 l2ZSB0aGVt IHRoZSByZX NvdXJjZXMg dG8gaW52ZX N0IGluIG5l dyBkcnVnIG RldmVsb3Bt ZW50Ljxicj 45LiBFbXBs b3llZS1Gcm llbmRseSBQ b2xpY2llcz ogT25vIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBKYXBhbi 4gSXQgaGFz IGEgcG9zaX RpdmUgd29y ayBjdWx0dX JlIGFuZCBl bXBsb3llZS 1mcmllbmRs eSBwb2xpY2 llcywgd2hp Y2ggaGF2ZS BoZWxwZWQg YXR0cmFjdC BhbmQgcmV0 YWluIHRvcC B0YWxlbnQu PGJyPjEwLi BDb21taXRt ZW50IHRvIF N1c3RhaW5h YmlsaXR5Oi BPbm8gaXMg Y29tbWl0dG VkIHRvIHN1 c3RhaW5hYm xlIGRldmVs b3BtZW50IG FuZCBoYXMg c2V0IHRhcm dldHMgZm9y IHJlZHVjaW 5nIGl0cyBl bnZpcm9ubW VudGFsIGlt cGFjdC4gVG hlIGNvbXBh bnkgYWxzby BzdXBwb3J0 cyB2YXJpb3 VzIHNvY2lh bCBpbml0aW F0aXZlcyBh bmQgaXMgd2 9ya2luZyB0 b3dhcmRzIG J1aWxkaW5n IGEgbW9yZS BzdXN0YWlu YWJsZSBmdX R1cmUu
What the company's business model?
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIE9uby BQaGFybWFj ZXV0aWNhbC BDb21wYW55 IGlzIGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g dGhlIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIHNh bGUgb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG lzIGJhc2Vk IG9uIHByb3 ZpZGluZyBp bm5vdmF0aX ZlIGFuZCBl ZmZlY3Rpdm UgbWVkaWNh bCBzb2x1dG lvbnMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMgYW5kIG 1lZGljYWwg Y29uZGl0aW 9ucy48YnI+ VGhleSBjb2 xsYWJvcmF0 ZSB3aXRoIH Jlc2VhcmNo IGluc3RpdH V0ZXMsIHVu aXZlcnNpdG llcywgYW5k IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyB0byBkZX ZlbG9wIG5l dyBkcnVncy BhbmQgdHJl YXRtZW50cy 4gT25vIFBo YXJtYWNldX RpY2FsIGFs c28gaGFzIG Egc3Ryb25n IGZvY3VzIG 9uIGludmVz dGluZyBpbi BjdXR0aW5n LWVkZ2UgdG VjaG5vbG9n aWVzIGFuZC Bjb250aW51 b3VzbHkgaW 1wcm92aW5n IHRoZWlyIG V4aXN0aW5n IHByb2R1Y3 RzLjxicj5U aGUgY29tcG FueSdzIG1h aW4gc291cm NlIG9mIHJl dmVudWUgY2 9tZXMgZnJv bSB0aGUgc2 FsZXMgb2Yg dGhlaXIgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IGJvdGggaW 4gSmFwYW4g YW5kIGludG VybmF0aW9u YWxseS4gVG hleSBoYXZl IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgdGhhdC Bjb3ZlciB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzLCBzdWNo IGFzIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgaW5mZWN0 aW91cyBkaX NlYXNlcy48 YnI+T25vIF BoYXJtYWNl dXRpY2FsIG Fsc28gdXNl cyBhIGxpY2 Vuc2luZyBi dXNpbmVzcy Btb2RlbCB0 byBleHBhbm QgdGhlaXIg cHJvZHVjdC Bwb3J0Zm9s aW8gYnkgcG FydG5lcmlu ZyB3aXRoIG 90aGVyIGNv bXBhbmllcy B0byBkZXZl bG9wIGFuZC Bjb21tZXJj aWFsaXplIH RoZWlyIHBy b2R1Y3RzIG luIGRpZmZl cmVudCBtYX JrZXRzLiBU aGV5IGFsc2 8gb2ZmZXIg Y29udHJhY3 QgbWFudWZh Y3R1cmluZy BzZXJ2aWNl cyB0byBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG dlbmVyYXRp bmcgYWRkaX Rpb25hbCBy ZXZlbnVlLj xicj5JbiBh ZGRpdGlvbi B0byB0aGVp ciBjb21tZX JjaWFsIGFj dGl2aXRpZX MsIE9ubyBQ aGFybWFjZX V0aWNhbCBh bHNvIGludm VzdHMgaW4g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcyB0 byBjb250cm lidXRlIHRv IHRoZSB3ZW xsLWJlaW5n IG9mIHNvY2 lldHkuIFRo aXMgaW5jbH VkZXMgc3Vw cG9ydGluZy BoZWFsdGhj YXJlLXJlbG F0ZWQgcHJv amVjdHMgYW 5kIGluaXRp YXRpdmVzIG luIGRldmVs b3BpbmcgY2 91bnRyaWVz Ljxicj5Pdm VyYWxsLCB0 aGUgY29tcG FueSdzIGJ1 c2luZXNzIG 1vZGVsIGZv Y3VzZXMgb2 4gY29udGlu dW91cyBpbm 5vdmF0aW9u LCBzdHJhdG VnaWMgY29s bGFib3JhdG lvbnMsIGFu ZCBldGhpY2 FsIGJ1c2lu ZXNzIHByYW N0aWNlcyB0 byBwcm92aW RlIGhpZ2gt cXVhbGl0eS BhbmQgZWZm ZWN0aXZlIG 1lZGljYWwg c29sdXRpb2 5zIGZvciBw YXRpZW50cy B3b3JsZHdp ZGUu
Interesting facts about the company
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVE wySENGR0E3 dkdnVGtPa2 o0UGwud2Vi cCIgYWx0PS JPbm8gUGhh cm1hY2V1dG ljYWwiIHRp dGxlPSJPbm 8gUGhhcm1h Y2V1dGljYW wiICBjbGFz cz0iaW1nLW ZsdWlkIiBo ZWlnaHQ9OT Agd2lkdGg9 OTAgbG9hZG luZz0nbGF6 eScgc3R5bG U9J2JvcmRl ci1yYWRpdX M6IDZweDsn PgoKICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdmbG V4OiAxOyB0 ZXh0LWFsaW duOiBjZW50 ZXI7IG1hcm dpbi1sZWZ0 OiA1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPHAgc3 R5bGU9J2Zv bnQtc2l6ZT ogMjZweDsg Y29sb3I6IC MzMzM7IG1h cmdpbi1ib3 R0b206IDE1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIPCfk4 ggV2FudCB0 byByZWFkIG 1vcmUgYWJv dXQgT25vIF BoYXJtYWNl dXRpY2FsPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+TnSBKb2 luIHVzIGFu ZCBncmFiIH lvdXIgY29w eSBvZiA8aT 4iVGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrcyI8L2k+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBiV0Zy WlhNZ2RHIE ZpYkdWMGN6 eGkgY2o0eE xpQkdiMyBW dVpHVmtJR2 x1IElERTNN VGM2SUYgUm 9aU0JQYm04 ZyBVR2hoY2 0xaFkyIFYx ZEdsallXd2 cgWTI5dGNH RnVlUyBCM1 lYTWdabTkx IGJtUmxaQ0 JwYmkgQXhO ekUzSUdGei BJR0VnZEhK aFpHIGwwYV c5dVlXd2cg YUdWeVltRn NJRyAxbFpH bGphVzVsIE lITjBiM0ps SUcgbHVJRT l6WVd0aCBM Q0JLWVhCaG JpIDRnU1hR Z2QyRnogSU dOaGJHeGxa QyBCUGJtOG dSMlZ1IGVt RmxiVzl1SU YgTm9iM1Js Ymk0OCBZbk krTWk0Z1JX IDUwWlhKbF pDQjAgYUdV Z2NHaGhjbS AxaFkyVjFk R2xqIFlXd2 dhVzVrZFgg TjBjbmtnYV c0ZyBNVGc1 T1RvZ1NXID RnTVRnNU9T d2cgZEdobE lHTnZiWCBC aGJua2djM1 JoIGNuUmxa Q0JwYlggQn ZjblJwYm1j ZyBjR2hoY2 0xaFkyIFYx ZEdsallXd2 cgY21GM0lH MWhkRyBWeW FXRnNjeUJt IGNtOXRJR0 ZpY20gOWha Q0JoYm1RZy BaVzUwWlhK bFpDIEIwYU dVZ2NHaGgg Y20xaFkyVj FkRyBsallX d2dhVzVrIG RYTjBjbmt1 UEcgSnlQak 11SUVacCBj bk4wSUVwaG NHIEZ1WlhO bElHTnYgYl hCaGJua2dk RyA4Z2JXRn VkV1poIFkz UjFjbVVnY0 cgVnVhV05w Ykd4cCBiam 9nU1c0Z01U IGswTml3Z1 QyNXYgSUZC b1lYSnRZVy BObGRYUnBZ MkZzIElHSm xZMkZ0WlMg QjBhR1VnWm 1seSBjM1Fn U21Gd1lXID VsYzJVZ1ky OXQgY0dGdW VTQjBieSBC dFlXNTFabU ZqIGRIVnla U0J3WlcgNX BZMmxzYkds dSBManhpY2 o0MExpIEJF WlhabGJHOX cgWldRZ1Nt RndZVyA3aW dKbHpJR1pw IGNuTjBJSF J5WVcgNXhk V2xzYVhwbC Bjam9nU1c0 Z01UIGsxTl N3Z2RHaGwg SUdOdmJYQm hibiBrZ1pH VjJaV3h2IG NHVmtJRXBo Y0cgRnU0b0 NaY3lCbSBh WEp6ZENCMG NtIEZ1Y1hW cGJHbDYgWl hJZ1kyRnNi RyBWa0lFVn NaVzVwIGRX MGdSV3hwZU cgbHlManhp Y2o0MSBMaU JNWVhWdVky IGdnYjJZZ1 ptbHkgYzNR Z1pISjFaeS BCbWIzSWdh SGx3IFpYSj BaVzV6YVcg OXVPaUJKYm lBeCBPVFkz TENCUGJtID hnVUdoaGNt MWggWTJWMW RHbGpZVyB3 Z2JHRjFibU 5vIFpXUWdk R2hsSUcgWn Bjbk4wSUdG dSBkR2xvZV hCbGNuIFJs Ym5OcGRtVW cgWkhKMVp5 QnBiaSBCS1 lYQmhiaUJq IFlXeHNaV1 FnUTIgRndi M1JsYmk0OC BZbkkrTmk0 Z1NXIDUwY2 05a2RXTjAg YVc5dUlHOW 1JSCBSb1pT Qm1hWEp6IG RDQktZWEJo Ym0gVnpaUz F0WVdSbCBJ R0Z1ZEdsal lXIDVqWlhJ Z1pISjEgWn pvZ1NXNGdN VCBrM05Dd2 dkR2hsIElH TnZiWEJoYm 4ga2dhVzUw Y205ayBkV0 5sWkNCMGFH IFVnWm1seW MzUWcgU21G d1lXNWxjMi BVdGJXRmta U0JoIGJuUn BZMkZ1WTIg VnlJR1J5ZF djZyBZMkZz YkdWa0lFIE p2YzJOb0lG Qm8gWVhKdF lTd2dkMiBo cFkyZ2dhWE 1nIGMzUnBi R3dnZDIgbG taV3g1SUhW eiBaV1FnZE c5a1lYIGt1 UEdKeVBqY3 UgSUVOdmJH eGhZbSA5eV lYUnBiMjRn IGQybDBhQ0 JNYVcgeHNl VG9nU1c0Zy BNVGs0TWl3 Z1QyIDV2SU ZCb1lYSnQg WVdObGRYUn BZMiBGc0lH VnVkR1Z5IF pXUWdhVzUw YnkgQmhJR0 52Ykd4aCBZ bTl5WVhScG IyIDRnZDJs MGFDQkYgYk drZ1RHbHNi SCBrZ1lXNW tJRU52IGJY QmhibmtnZE cgOGdaR1Yy Wld4diBjQ0 JoYm1RZ2JX IEZ5YTJWME lIQm8gWVhK dFlXTmxkWC BScFkyRnNJ SEJ5IGIyUj FZM1J6SUcg bHVJRXBoY0 dGdSBManhp Y2o0NExpIE JRWVhKMGJt VnkgYzJocG NDQjNhWCBS b0lFSnlhWE 4wIGIyd3RU WGxsY24gTW dVM0YxYVdK aSBPaUJKYm lBeU1EIEEy TENCUGJtOG cgVUdoaGNt MWhZMiBWMW RHbGpZV3dn IGMybG5ibV ZrSUcgRnVJ R0ZuY21WbC BiV1Z1ZENC M2FYIFJvSU VKeWFYTjAg YjJ3dFRYbG xjbiBNZ1Uz RjFhV0ppIE lHWnZjaUIw YUcgVWdZMj h0WkdWMiBa V3h2Y0cxbG JuIFFnWVc1 a0lHTnYgTF dOdmJXMWxj bSBOcFlXeH BlbUYwIGFX OXVJRzltSU cgUnlkV2R6 SUdadiBjaU JqWVc1alpY IElzSUdObG JuUnkgWVd3 Z2JtVnlkbS A5MWN5Qnpl WE4wIFpXMG daR2x6YjMg SmtaWEp6TE NCaCBibVFn WVhWMGIyIG x0YlhWdVpT QmsgYVhObF lYTmxjeSA0 OFluSStPUz RnIFIyeHZZ bUZzSUcgVj RjR0Z1YzJs diBiam9nVD I1dklGIEJv WVhKdFlXTm wgZFhScFky RnNJRyBoaG N5QmxlSEJo IGJtUmxaQ0 JwZEggTWdZ blZ6YVc1bC BjM01nZEc4 Z2IzIFpsY2 lBNE5DQmog YjNWdWRISn BaWCBNZ1lX NWtJSEpsIF oybHZibk1n WVggSnZkVz VrSUhSbyBa U0IzYjNKc1 pDIHdnZDJs MGFDQmggSU dadlkzVnpJ RyA5dUlFRn phV0VzIElF NXZjblJvSU UgRnRaWEpw WTJFcyBJR0 Z1WkNCRmRY IEp2Y0dVdV BHSnkgUGpF d0xpQlRkWC BOMFlXbHVZ V0pzIFpTQm taWFpsYkcg OXdiV1Z1ZE RvZyBWR2hs SUdOdmJYIE JoYm5rZ2FY TWcgWTI5dG JXbDBkRyBW a0lIUnZJSE 4xIGMzUmhh VzVoWW0geG xJR1JsZG1W cyBiM0J0Wl c1MElHIEZ1 WkNCb1lYTW cgYzJWMElH ZHZZVyB4ek lIUnZJSEps IFpIVmpaU0 JwZEggTWda VzUyYVhKdi BibTFsYm5S aGJDIEJwYl hCaFkzUXMg SUhCeWIyMX ZkRyBVZ1pH bDJaWEp6IG FYUjVJR0Z1 WkMgQnBibU 5zZFhOcCBi MjRzSUdGdV pDIEJqYjI1 MGNtbGkgZF hSbElIUnZJ SCBOdlkybG xkSGtnIGRH aHliM1ZuYU MgQjJZWEpw YjNWeiBJR2 x1YVhScFlY IFJwZG1Wek xnPT0KICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg
See Company Q&A
Ono Pharmaceutical

πŸ“Š Get full analytics about Ono Pharmaceutical

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal